Erich Weiß
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
Papers in
- Oncology 3
- Cancer Treatment and Pharmacology 1
- PARP inhibition in cancer therapy 1
- HER2/EGFR in Cancer Research 1
-
- Breast Lesions and Carcinomas 2
- Co-authors
- Jens Huober (3 shared papers)Sibylle Loibl (3 shared papers)Keyur Mehta (3 shared papers)Carsten Denkert (2 shared papers)Silvia Darb‐Esfahani (2 shared papers)F Khandan (2 shared papers)Christoph Thomssen (2 shared papers)Hans Tesch (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Breast Cancer Research and Treatment (1 paper)University Library Heidelberg (1 paper)ZfV - Zeitschrift für Geodäsie, Geoinformation und Landmanagement (1 paper)
- Partner nations
- Germany
In The Last Decade
Erich Weiß
3 papers receiving 327 citations
Peers
Comparison fields: 5 of 47
- Cancer Research 237
- Oncology 241
- Pathology and Forensic Medicine 84
- Genetics 37
- Molecular Biology 83
Countries citing papers authored by Erich Weiß
This map shows the geographic impact of Erich Weiß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erich Weiß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erich Weiß more than expected).
Fields of papers citing papers by Erich Weiß
This network shows the impact of papers produced by Erich Weiß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erich Weiß. The network helps show where Erich Weiß may publish in the future.
Co-authors
The 25 scholars most cited alongside Erich Weiß, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 220 | |
| 2 | 2011 | 75 | |
| 3 | 2009 | 39 | |
| 4 | Ein Zwischenruf zum Pro und Kontra der Landentwicklung nach § 86 Flurbereinigungsgesetz | 2008 | 1 |
| 5 | 2015 | 0 |
About Erich Weiß
Erich Weiß is a scholar working on Oncology, Pathology and Forensic Medicine, Cancer Research, Molecular Biology and Law, having authored 5 papers that have together received 335 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (2 papers), Breast Lesions and Carcinomas (2 papers), Cancer Treatment and Pharmacology (1 paper), PARP inhibition in cancer therapy (1 paper), DNA Repair Mechanisms (1 paper), Integrated Circuits and Semiconductor Failure Analysis (1 paper), Law and Political Science (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Cancer Research (237 citations), Oncology (241 citations), Pathology and Forensic Medicine (84 citations), Genetics (37 citations) and Molecular Biology (83 citations). Erich Weiß has collaborated with scholars based in Germany. Frequent co-authors include Jens Huober, Sibylle Loibl, Keyur Mehta, Carsten Denkert, Silvia Darb‐Esfahani, F Khandan, Christoph Thomssen, Hans Tesch, Maik Hauschild and B. Högel. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, University Library Heidelberg and ZfV - Zeitschrift für Geodäsie, Geoinformation und Landmanagement.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.